94 web-programmer-developer-"https:"-"https:"-"https:" positions at Fred Hutchinson Cancer Center in United States
Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
; Immunology and Vaccine Development; and Infectious Disease Sciences. The Program Operations Director (POD) for the Immunology and Vaccine Development (IVD) Program provides oversight and direction for a
-
. This is a time-limited position and initial funding commitment is for a 12-month period only. Responsibilities HutchCAN Program Development Assist with identifying and recruiting staff from across
-
stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. The Mouse Development Lab (MoDeL) at Fred Hutch is dedicated to advancing mouse model development
-
the exciting research and outreach activities of the TRACER program. This is an ideal opportunity for students interested in sciences, communications, public health, digital media, or nonprofit outreach. This is
-
management for a team of Fred Hutch developers/engineers. The position is on the UX, Design & Web Development team that includes 20+ team members within Fred Hutch's Marketing & Communications department
-
communications strategies that promote domestic HIV clinical research efforts, including web development, social media, as well as academic and non-academic writing. Share tasks, provide coverage, and support HANC
-
Manager of Research Finance in the Infectious Disease Sciences Program. The Research Administrator III will design, develop, and be responsible for overseeing and managing budget/fiscal systems, policies
-
, and concerns in a timely manner Identify and resolve operational problems Propose/advise in program development and improvements Track and order supplies and enter financial requisitions as directed
-
website for further information. The Singhvi Lab provides a supportive environment that strongly emphasizes individualized mentoring. Upon joining, we will prioritize your continued development as an
-
on improving existing, and developing novel, antibody-based immunotherapies, and rendering them safer for clinical application. Current projects include preclinical drug development/testing (in part with